These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10838574)

  • 21. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

  • 22. INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN
    Gramegna A; Moore JE; McCaughan J; Millar BC; Ewing J; Elborn JS; Blasi F; Downey DG
    Ulster Med J; 2018 May; 87(2):129-130. PubMed ID: 29867273
    [No Abstract]   [Full Text] [Related]  

  • 23. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.
    Schobert M; Jahn D
    Int J Med Microbiol; 2010 Dec; 300(8):549-56. PubMed ID: 20951638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa Proteome under Hypoxic Stress Conditions Mimicking the Cystic Fibrosis Lung.
    Kamath KS; Krisp C; Chick J; Pascovici D; Gygi SP; Molloy MP
    J Proteome Res; 2017 Oct; 16(10):3917-3928. PubMed ID: 28832155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors.
    Deretic V; Schurr MJ; Boucher JC; Martin DW
    J Bacteriol; 1994 May; 176(10):2773-80. PubMed ID: 8188579
    [No Abstract]   [Full Text] [Related]  

  • 29. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis unit.
    Denton M; Littlewood JM; Brownlee KG; Conway SP; Todd NJ
    Lancet; 1996 Dec; 348(9041):1596-7. PubMed ID: 8950918
    [No Abstract]   [Full Text] [Related]  

  • 30. Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
    Ang JY; Abdel-Haq N; Zhu F; Thabit AK; Nicolau DP; Satlin MJ; van Duin D
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5627-30. PubMed ID: 27664282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrosative stress inhibits production of the virulence factor alginate in mucoid Pseudomonas aeruginosa.
    Wood SR; Firoved AM; Ornatowski W; Mai T; Deretic V; Timmins GS
    Free Radic Res; 2007 Feb; 41(2):208-15. PubMed ID: 17364947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
    Pang Z; Raudonis R; Glick BR; Lin TJ; Cheng Z
    Biotechnol Adv; 2019; 37(1):177-192. PubMed ID: 30500353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic Fibrosis Lung Function Decline after Within-Host Evolution Increases Virulence of Infecting
    Jorth P; Durfey S; Rezayat A; Garudathri J; Ratjen A; Staudinger BJ; Radey MC; Genatossio A; McNamara S; Cook DA; Aitken ML; Gibson RL; Yahr TL; Singh PK
    Am J Respir Crit Care Med; 2021 Mar; 203(5):637-640. PubMed ID: 33137262
    [No Abstract]   [Full Text] [Related]  

  • 34. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
    Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G
    Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Güzel C; Gerçeker AA
    J Antibiot (Tokyo); 2012 Feb; 65(2):83-6. PubMed ID: 22126897
    [No Abstract]   [Full Text] [Related]  

  • 37. Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):406S. PubMed ID: 8878950
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutators.
    Bulman ZP; Sutton MD; Ly NS; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4343-6. PubMed ID: 25918151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas cepacia in cystic fibrosis patients.
    Prince A
    Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
    [No Abstract]   [Full Text] [Related]  

  • 40. Molybdate transporter ModABC is important for Pseudomonas aeruginosa chronic lung infection.
    Périnet S; Jeukens J; Kukavica-Ibrulj I; Ouellet MM; Charette SJ; Levesque RC
    BMC Res Notes; 2016 Jan; 9():23. PubMed ID: 26758577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.